High-performance thin-layer chromatographic determination of flurbiprofen in plasma

被引:19
作者
Dhavse, VV
Parmar, DV
Devarajan, PV
机构
[1] UNIV BOMBAY,DEPT CHEM TECHNOL AUTONOMOUS,PHARMACEUT SCI & TECHNOL DIV,MUMBAI 400019,INDIA
[2] SIR JJ GRP HOSP,GRANT MED COLL,DEPT PHARMACOL,CLIN PHARMACOL LAB,MUMBAI 400008,INDIA
来源
JOURNAL OF CHROMATOGRAPHY B | 1997年 / 694卷 / 02期
关键词
flurbiprofen;
D O I
10.1016/S0378-4347(97)00046-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-performance thin-layer chromatographic (HPTLC) method for the assay of flurbiprofen in plasma is reported. The drug was extracted from acidified plasma with hexane-diethyl ether (80:20). The mobile phase composition was n-hexane-ethyl acetate-glacial acetic acid (60:30:10). Densitometric analysis of flurbiprofen was carried out at 247 nm. The calibration curves of flurbiprofen in methanol and in plasma were linear in the range 40-400 ng. The mean values of correlation coefficient, slope and intercept were 0.995+/-0.003, 0.075+/-0.002 and 4.39+/-0.05 for standard curves in methanol and 0.992+/-0.002, 0.066+/-0.007 and 3.40+/-0.72 for standard curves in plasma, respectively. The limit of quantitation for flurbiprofen in human plasma was 40 ng, and no interference was found from endogenous compounds. The recovery of flurbiprofen from human plasma using the described extraction procedure was about 87%. The coefficient of variation for within-day and between-day analyses was 2.53% and 3.96% for 200 ng and 1.76% and 2.30% for 400 ng flurbiprofen concentration, respectively. The method was utilized to monitor plasma concentration of flurbiprofen post administration of sustained release capsules in human patient volunteers. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:449 / 453
页数:5
相关论文
共 18 条
[1]   SIMULTANEOUS DETERMINATION OF FLURBIPROFEN AND ITS MAJOR METABOLITE IN PHYSIOLOGICAL FLUIDS USING LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
ADAMS, WJ ;
BOTHWELL, BE ;
BOTHWELL, WM ;
VANGIESSEN, GJ ;
KAISER, DG .
ANALYTICAL CHEMISTRY, 1987, 59 (11) :1504-1509
[2]   DETERMINATION OF FLURBIPROFEN IN HUMAN-SERUM BY REVERSE-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
ALBERT, KS ;
GILLESPIE, WR ;
RAABE, A ;
GARRY, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (12) :1823-1825
[3]  
ASKHOLT J, 1986, ACTA PHARMACOL TOX, V59, P382
[4]   STEREOSPECIFIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC (HPLC) ASSAY OF FLURBIPROFEN IN BIOLOGICAL SPECIMENS [J].
BERRY, BW ;
JAMALI, F .
PHARMACEUTICAL RESEARCH, 1988, 5 (02) :123-125
[5]   FLURBIPROFEN - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN RHEUMATIC DISEASES [J].
BROGDEN, RN ;
HEEL, RC ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1979, 18 (06) :417-438
[6]  
Deshpande S.G., 1995, INDIAN DRUGS, V32, P227
[7]   STEREOSELECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF FLURBIPROFEN IN HUMAN PLASMA [J].
GEISSLINGER, G ;
MENZELSOGLOWEK, S ;
SCHUSTER, O ;
BRUNE, K .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 573 (01) :163-167
[8]   DETERMINATION OF AMITRIPTYLINOXIDE AND ITS MAJOR METABOLITES AMITRIPTYLINE AND NORTRIPTYLINE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
TERLINDEN, R ;
BORBE, HO .
JOURNAL OF CHROMATOGRAPHY, 1986, 382 :372-376
[9]   PHARMACOKINETICS OF FLURBIPROFEN [J].
KAISER, DG ;
BROOKS, CD ;
LOMEN, PL .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (3A) :10-15
[10]   GLC DETERMINATION OF DL-2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID (FLURBIPROFEN) IN PLASMA [J].
KAISER, DG ;
SHAW, SR ;
VANGIESSEN, GJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (04) :567-570